Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KCND2 Antikörper (AA 501-630)

KCND2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7163977
  • Target Alle KCND2 Antikörper anzeigen
    KCND2 (Potassium Voltage-Gated Channel, Shal-Related Subfamily, Member 2 (KCND2))
    Bindungsspezifität
    • 15
    • 10
    • 9
    • 8
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 501-630
    Reaktivität
    • 55
    • 36
    • 34
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 55
    • 3
    • 1
    Kaninchen
    Klonalität
    • 56
    • 3
    Polyklonal
    Konjugat
    • 27
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser KCND2 Antikörper ist unkonjugiert
    Applikation
    • 44
    • 27
    • 23
    • 13
    • 9
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    Antigen Affinity Purified
    Immunogen
    Recombinant Human Potassium voltage-gated channel subfamily D member 2 protein (501-630AA)
    Isotyp
    IgG
    Top Product
    Discover our top product KCND2 Primärantikörper
  • Applikationshinweise
    Recommended dilution: WB:1:1000-1:5000,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    KCND2 (Potassium Voltage-Gated Channel, Shal-Related Subfamily, Member 2 (KCND2))
    Andere Bezeichnung
    KCND2 (KCND2 Produkte)
    Synonyme
    KCND2 antikoerper, si:dkey-24j9.3 antikoerper, si:dkeyp-97c5.3 antikoerper, DKFZp459P1550 antikoerper, AI839615 antikoerper, AW555701 antikoerper, Kv4.2 antikoerper, R75121 antikoerper, mKIAA1044 antikoerper, KV4.2 antikoerper, RK5 antikoerper, Shal1 antikoerper, potassium voltage-gated channel subfamily D member 2 antikoerper, potassium voltage-gated channel, Shal-related subfamily, member 2 antikoerper, potassium voltage-gated channel, Shal-related family, member 2 antikoerper, KCND2 antikoerper, kcnd2 antikoerper, Kcnd2 antikoerper, LOC101669961 antikoerper
    Hintergrund

    Background: Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain. Mediates the major part of the dendritic A-type current I(SA) in brain neurons (By similarity). This current is activated at membrane potentials that are below the threshold for action potentials. It regulates neuronal excitability, prolongs the latency before the first spike in a series of action potentials, regulates the frequency of repetitive action potential firing, shortens the duration of action potentials and regulates the back-propagation of action potentials from the neuronal cell body to the dendrites. Contributes to the regulation of the circadian rhytm of action potential firing in suprachiasmatic nucleus neurons, which regulates the circadian rhythm of locomotor activity (By similarity). Functions downstream of the metabotropic glutamate receptor GRM5 and plays a role in neuronal excitability and in nociception mediated by activation of GRM5 (By similarity). Mediates the transient outward current I(to) in rodent heart left ventricle apex cells, but not in human heart, where this current is mediated by another family member. Forms tetrameric potassium-selective channels through which potassium ions pass in accordance with their electrochemical gradient (PubMed:10551270, PubMed:15454437, PubMed:14695263, PubMed:14623880, PubMed:14980201, PubMed:16934482, PubMed:24811166, PubMed:24501278). The channel alternates between opened and closed conformations in response to the voltage difference across the membrane (PubMed:11507158). Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions of KCND2 and KCND3, channel properties depend on the type of pore-forming alpha subunits that are part of the channel. In vivo, membranes probably contain a mixture of heteromeric potassium channel complexes. Interaction with specific isoforms of the regulatory subunits KCNIP1, KCNIP2, KCNIP3 or KCNIP4 strongly increases expression at the cell surface and thereby increases channel activity, it modulates the kinetics of channel activation and inactivation, shifts the threshold for channel activation to more negative voltage values, shifts the threshold for inactivation to less negative voltages and accelerates recovery after inactivation (PubMed:15454437, PubMed:14623880, PubMed:14980201, PubMed:19171772, PubMed:24501278, PubMed:24811166). Likewise, interaction with DPP6 or DPP10 promotes expression at the cell membrane and regulates both channel characteristics and activity (By similarity).

    Aliases: KCD2 antibody, KCND 2 antibody, KCND2 antibody, KCND2_HUMAN antibody, KIAA1044 antibody, MGC119702 antibody, MGC119703 antibody, Potassium voltage gated channel Shal related subfamily member 2 antibody, Potassium voltage-gated channel subfamily D member 2 antibody, RK 5 antibody, RK5 antibody, Voltage gated potassium channel Kv4.2 antibody, Voltage gated potassium channel subunit Kv4.2 antibody, Voltage sensitive potassium channel antibody, Voltage-gated potassium channel subunit Kv4.2 antibody

    UniProt
    Q9NZV8
Sie sind hier: